Skip to main content
Log in

Estimating key parameters in FOBT screening for colorectal cancer

  • Original Paper
  • Published:
Cancer Causes & Control Aims and scope Submit manuscript

Abstract

Objectives

The association between screening sensitivity, transition probability, and individual’s age in FOBT for colorectal cancer are explored, for both males and females.

Methods

We apply the statistical method developed by Wu et al. [1] using the Minnesota colorectal cancer study group data, to make Bayesian inference for the age-dependent screening test sensitivity, the age-dependent transition probability from disease-free to preclinical state, and the sojourn time distribution, for both male and female participants in a periodic screening program. This gives us more information on the effectiveness of the fecal occult blood test in colorectal cancer detection.

Results

The sensitivity appears to increase with age for both genders. However, the posterior mean sensitivity is not monotonic with age for males; it has a peak around age 74. The standard errors of the sensitivity are not monotone either; there is a minimum at age 69 for males and at age 78 for females. The age-dependent transition probability is not a monotone function of age; it has a single maximum at age 72 for males and a single maximum at age 75 for females. The age dependency seems more dramatic for females than for males. The posterior mean sojourn time is 4.08 years for males and 2.41 years for females, with a posterior median of 1.66 years for males and 1.88 years for females. The 95% highest posterior density (HPD) interval is (0.97, 20.28) for males and (1.15, 5.96) for females, which are very large ranges, especially for males. The reason might be that there were fewer men than women in the annual screening program.

Conclusion

Reliable estimates of age-dependent sensitivity and transition probability are of great value to policy-makers regarding the initial age for colorectal cancer screening exams. We found that the mean sojourn time for males is much longer than that for females, which may imply that FOBT screening for colorectal cancer may be more effective for males than for females.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Wu D, Rosner GL, Broemeling LD (2005) MLE and Bayesian inference of age-dependent sensitivity and transition probability in periodic screening. Biometrics 61(4):1056–1063. doi:10.1111/j.1541-0420.2005.00361.x

    Article  PubMed  Google Scholar 

  2. Cancer facts and figures (2007) American Cancer Society. http://www.cancer.org/downloads/stt/caff2007pwsecured.pdf

  3. SEER Fast Stats Results, NIH. http://seer.cancer.gov/statfacts/html/colorect.html

  4. Anderson WF, Guyton KA, Hiatt RA et al (2002) Colorectal cancer screening for person at average risk. J Natl Cancer Inst 94:1126–1133

    PubMed  Google Scholar 

  5. Church TR (2005) Offering patients colorectal cancer screening. J Natl Cancer Inst 97:328–329

    Article  PubMed  Google Scholar 

  6. Mandel JS, Church TR, Ederer F et al (1999) Colorectal cancer mortality: effectiveness of biennial screening for fecal occult blood. J Natl Cancer Inst 91:434–437. doi:10.1093/jnci/91.5.434

    Article  PubMed  CAS  Google Scholar 

  7. Prevost TC, Launoy G, Duffy SW et al (1998) Estimating sensitivity and sojourn time in screening for colorectal cancer. Am J Epidemiol 148(6):609–619

    PubMed  CAS  Google Scholar 

  8. Walter SD, Day NE (1983) Estimation of the duration of a preclinical disease state using screening data. Am J Epidemiol 118:856–886

    Google Scholar 

  9. Church TR, Ederer F, Mandel JS (1997) Fecal occult blood screening in the Minnesota study: sensitivity of the screening test. J Natl Cancer Inst 89:1440–1457. doi:10.1093/jnci/89.19.1440

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

The authors would like to thank Dr. Stuart Baker from National Cancer Institute for valuable comments and suggestions. This research was partially supported by the NIH grant CA-115012.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Dongfeng Wu.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wu, D., Erwin, D. & Rosner, G.L. Estimating key parameters in FOBT screening for colorectal cancer. Cancer Causes Control 20, 41–46 (2009). https://doi.org/10.1007/s10552-008-9215-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10552-008-9215-9

Keywords

Navigation